Free papers

1. MDSC: a new player in HIV immunopathogenesis.

AIDS 2012; 26 (12): 1567-9

2. Contribution of MyD88 to the Tumor Exosome-Mediated Induction of Myeloid Derived Suppressor Cells.

Am J Pathol 2010; 176 (5): 2490-9

3. Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer.

Blood 2013; 122 (7): 1105-13

4. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.

Blood 2013; 121 (10): 1760-8

5. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.

Blood 2011; 118 (20): 5498-505

6. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

Blood 2011; 118 (8): 2254-65

7. Myeloid‐Derived Suppressor Cells Limit the Inflammation by Promoting T Lymphocyte Apoptosis in the Spinal Cord of a Murine Model of Multiple Sclerosis.

Brain Pathol 2011; 21 (6): 678-91

8. Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.

Cancer Immunol Immunother 2013; 62 (2): 383-91

9. Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.

Cancer Immunol Immunother 2013; 62 (2): 225-36

10. Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine.

Cancer Immunol Immunother 2013; 62 (1): 171-82

11. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.

Cancer Immunol Immunother 2012; 61 (9): 1373-85

12. Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2â€Č-deoxycytidine.

Cancer Immunol Immunother 2010; 59 (5): 697-706

13. Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells.

Cancer Immunol Immunother 2009; 58 (5): 687-97

14. Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression and reduces tumor metastasis and recurrence.

Cancer Immunol Immunother 1995; 41 (1): 37-45

15. Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner.

Cancer Res 2013; 73 (10): 3007-18

16. Antigen-specific CD4+ T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling.

Cancer Res 2012; 72 (4): 928-38

17. PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment.

Cancer Res 2011; 71 (24): 7463-70

18. Api6/AIM/Spα/CD5L Overexpression in Alveolar Type II Epithelial Cells Induces Spontaneous Lung Adenocarcinoma.

Cancer Res 2011; 71 (16): 5488-99

19. Myeloid-derived Suppressor Cells Inhibit T Cell Activation by Depleting Cystine and Cysteine.

Cancer Res 2010; 70 (1): 68-77

20. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid derived suppressor cells from the bone marrow.

Cancer Res 2009; 69 (8): 3554-62

21. A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.

Cell Res 2013; 23 (3): 394-408

22. STAT3: A Target to Enhance Antitumor Immune Response.

Curr Top Microbiol Immunol 2011; 344 (ä): 41-59

23. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site.

Eur J Immunol 2011; 41 (3): 749-59

24. Agonistic Anti-CD137 Monoclonal Antibody Treatment Induces CD11b+Gr-1+ Myeloid-derived Suppressor Cells.

Immune Netw 2010; 10 (3): 104-8

25. Paired Immunoglobin Like Receptor-B regulates the suppressive function and fate of myeloid derived suppressor cells.

Immunity 2011; 34 (3): 385-95

26. microRNAs as potential regulators of myeloid-derived suppressor cell expansion.

Innate Immun 2014; 20 (3): 227-38

27. Hematopoietic Cytokine-Induced Transcriptional Regulation and Notch Signaling as Modulators of MDSC Expansion.

Int Immunopharmacol 2011; 11 (7): 807-13

28. TNF signaling drives myeloid-derived suppressor cell accumulation.

J Clin Invest 2012; 122 (11): 4094-104

29. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.

J Exp Med 2010; 207 (7): 1453-64

30. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.

J Exp Med 2008; 205 (10): 2235-49

31. In Vivo Ablation of Plasmacytoid Dendritic Cells Inhibits Autoimmunity through Expansion of Myeloid-Derived Suppressor Cells.

J Immunol 2013; 190 (6): 2631-40

32. The receptor for advanced glycation end-products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.

J Immunol 2013; 190 (3): 1372-9

33. TIM-3 Regulates Innate Immune Cells to Induce Fetomaternal Tolerance.

J Immunol 2013; 190 (1): 88-96

34. Macrophage Migration Inhibitory Factor promotes tumor growth and metastasis by inducing Myeloid Derived Suppressor Cells in the tumor microenvironment.

J Immunol 2012; 189 (12): 5533-40

35. Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of the breast cancer cells.

J Immunol 2012; 189 (9): 4258-65

36. Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells.

J Immunol 2011; 187 (11): 6120-9

37. IL-33 expands suppressive CD11b+ Gr-1int and regulatory T cells (Treg) including ST2L+ Foxp3+ cells and mediates Treg-dependent promotion of cardiac allograft survival.

J Immunol 2011; 187 (9): 4598-610

38. Myeloid-Specific Expression of Human Lysosomal Acid Lipase Corrects Malformation and Malfunction of Myeloid-derived Suppressive Cells in lal−/− Mice.

J Immunol 2011; 187 (7): 3854-66

39. Phagocytosis a potential mechanism for myeloid derived suppressor cell regulation of CD8+ T cell function mediated through PD-1 and PD-L1 interaction.

J Immunol 2011; 187 (5): 2291-301

40. Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.

J Immunol 2010; 185 (3): 1383-92

41. Myeloid-specific Expression of Api6/AIM/Spα Induces Systemic Inflammation and Adenocarcinoma in the Lung.

J Immunol 2009; 182 (3): 1648-59

42. Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1.

J Immunol 2008; 181 (7): 4666-75

43. Pivotal Advance: Tumor‐mediated induction of myeloid‐derived suppressor cells and M2‐polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells.

J Leukoc Biol 2010; 88 (5): 839-48

44. CD99-Dependent Expansion of Myeloid-Derived Suppressor Cells and Attenuation of Graft-Versus-Host Disease.

Mol Cells 2012; 33 (3): 259-67

45. Altered recognition of antigen is a novel mechanism of CD8+ T cell tolerance in cancer.

Nat Med 2007; 13 (7): 828-35

46. Resistance to Streptozotocin-Induced Autoimmune Diabetes in Absence of Complement C3: Myeloid-Derived Suppressor Cells Play a Role.

PLoS One 2013; 8 (6): ä

47. Inhibition of IL-17A in Tumor Microenvironment Augments Cytotoxicity of Tumor-Infiltrating Lymphocytes in Tumor-Bearing Mice.

PLoS One 2013; 8 (1): ä

48. Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines.

PLoS One 2012; 7 (8): ä

49. Murine Pancreatic Adenocarcinoma Dampens SHIP-1 Expression and Alters MDSC Homeostasis and Function.

PLoS One 2011; 6 (11): ä

50. Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol.

PLoS One 2011; 6 (4): ä

51. Generation of myeloid-derived suppressor cells using prostaglandin E2.

Transplant Res 2012; 1 (ä): 15

52. Myeloid-Derived Suppressor Cells (MDSC) Protect Islet Transplants via B7-H1 Mediated Enhancement of T Regulatory Cells.

Transplantation 2012; 93 (3): 272-82

53. Human Inhibitory Receptor ILT2 Amplifies CD11b+Gr1+ Myeloid-Derived Suppressor Cells that Promote Long-Term Survival of Allografts.

Transplantation 2008; 86 (8): 1125-34

54. Emerging Tim-3 functions in anti-microbial and tumor immunity.

Trends Immunol 2011; 32 (8): 345-9

Beyond PubMed : called unfree